IL-27 promotes Treg cell expression of CD122 and fitness at homeostasis
Abstract
Regulatory T (Treg) cells express high levels of the IL-27R, and in the setting of infection and autoimmunity, the cytokine IL-27 promotes Treg cell activities that mitigate tissue pathology. However, IL-27 appears dispensable for Treg cell development and maintenance as lineage-specific depletion of the IL-27R on Treg cells does not impact these populations at steady state. In contrast, when mice were generated in which the Treg compartment comprised a mix of IL-27R-sufficient and -deficient Treg cells, those that lacked IL-27R were at a competitive disadvantage. Aging experiments illustrate that IL-27R-deficient Treg cells are preferentially eroded, and this defect was associated with reduced expression of CD122, the β chain of the IL-2/15R. Moreover, blockade of CD122 led to a similar loss of Treg cells, and in vitro and in vivo studies highlight that IL-27 promotes Treg cell expression of CD122 and improves responsiveness to IL-2/15. These datasets reveal that homeostatic IL-27 signals provide a competitive advantage that shapes the composition of the Treg cell pool by modulating responsiveness to growth factors.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (16)
Zachary R. Lanzar
Department of Pathobiology, University of Pennsylvania
Daniel L. Aldridge
Department of Pathobiology, University of Pennsylvania
Elisa Cruz-Morales
Department of Pathobiology, University of Pennsylvania
Christian A. Howard
Department of Pathobiology, University of Pennsylvania
Isabella O. Conway
Department of Pathobiology, University of Pennsylvania
Zhe Zhong
Translational Science and Therapeutics Division, Fred Hutch Cancer Center
Julia N. Eberhard
Department of Pathobiology, University of Pennsylvania
Joseph A. Pereira
Department of Immunology, Blavatnik Institute, Harvard Medical School
Anthony T. Phan
Department of Pathobiology, University of Pennsylvania
Aaron M. Ring
Melissa Parker
Incyte Research Institute, Incyte Corporation
Chryssa Kanellopoulou
Incyte Research Institute, Incyte Corporation
Booki Min
Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine
Ross M. Kedl
Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine
David A. Christian
Department of Pathobiology, University of Pennsylvania
Christopher A. Hunter